The good news: We have a breakthrough cure for sickle-cell disease, using CRISPR and gene-editing technology.

The bad news: It’s owned by a private company that will charge $2.2M for a course of treatment.

Pharmaceutical research should be publicly-funded, and its results should go directly into public domain, where private providers can compete on price for manufacture and distribution. For a fraction of the money we spend on missiles and remote military bases, we can save so many lives instead.

“FDA approves cure for sickle cell disease, the first treatment to use gene-editing tool CRISPR”

#healthcare #medicine #capitalism

https://www.nbcnews.com/health/health-news/fda-approves-cure-sickle-cell-disease-first-treatment-use-gene-editing-rcna127979

FDA approves cure for sickle cell disease, the first treatment to use gene-editing tool CRISPR

The FDA approved a new treatment for sickle cell disease. The therapy is first to use the ground-editing tool CRISPR.

^{Berkeley Lovelace Jr. (NBC News)}